IRIS Accounts Production v24.3.2.46 14519791 Board of Directors Board of Directors Board of Directors Board of Directors 1.1.24 31.12.24 31.12.24 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh145197912023-12-31145197912024-12-31145197912024-01-012024-12-31145197912022-12-01145197912022-12-022023-12-31145197912023-12-3114519791ns15:EnglandWales2024-01-012024-12-3114519791ns14:PoundSterling2024-01-012024-12-3114519791ns10:Director12024-01-012024-12-3114519791ns10:Director22024-01-012024-12-3114519791ns10:Director32024-01-012024-12-3114519791ns10:Director42024-01-012024-12-3114519791ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3114519791ns10:SmallEntities2024-01-012024-12-3114519791ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3114519791ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3114519791ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3114519791ns10:FullAccounts2024-01-012024-12-3114519791ns10:RegisteredOffice2024-01-012024-12-3114519791ns5:CurrentFinancialInstruments2024-12-3114519791ns5:CurrentFinancialInstruments2023-12-3114519791ns5:ShareCapital2024-12-3114519791ns5:ShareCapital2023-12-3114519791ns5:RetainedEarningsAccumulatedLosses2024-12-3114519791ns5:RetainedEarningsAccumulatedLosses2023-12-3114519791ns5:PlantMachinery2024-01-012024-12-3114519791ns5:PlantMachinery2023-12-3114519791ns5:PlantMachinery2024-12-3114519791ns5:PlantMachinery2023-12-3114519791ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3114519791ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-31
REGISTERED NUMBER: 14519791 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 December 2024

for

Venture Health Group Ltd

Venture Health Group Ltd (Registered number: 14519791)






Contents of the Financial Statements
for the Year Ended 31 December 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Venture Health Group Ltd

Company Information
for the Year Ended 31 December 2024







DIRECTORS: Dr J D Broome
Dr S B Maddineni
Dr D C Shackley
Dr S K Tolofari





REGISTERED OFFICE: Ground Floor
Rear Barn
The Brookdale Centre
Knutsford
Cheshire
WA16 0SR





REGISTERED NUMBER: 14519791 (England and Wales)





ACCOUNTANTS: EBA
Ground Floor
Rear Barn
The Brookdale Centre
Knutsford
Cheshire
WA16 0SR

Venture Health Group Ltd (Registered number: 14519791)

Balance Sheet
31 December 2024

31.12.24 31.12.23
Notes £ £ £ £
FIXED ASSETS
Tangible assets 4 1,349 718

CURRENT ASSETS
Debtors 5 570,927 -
Cash at bank 314,111 182,803
885,038 182,803
CREDITORS
Amounts falling due within one year 6 657,718 114,030
NET CURRENT ASSETS 227,320 68,773
TOTAL ASSETS LESS CURRENT
LIABILITIES

228,669

69,491

PROVISIONS FOR LIABILITIES 337 136
NET ASSETS 228,332 69,355

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 228,232 69,255
228,332 69,355

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Venture Health Group Ltd (Registered number: 14519791)

Balance Sheet - continued
31 December 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 16 April 2025 and were signed on its behalf by:




Dr J D Broome - Director Dr S K Tolofari - Director




Dr S B Maddineni - Director Dr D C Shackley - Director


Venture Health Group Ltd (Registered number: 14519791)

Notes to the Financial Statements
for the Year Ended 31 December 2024

1. STATUTORY INFORMATION

Venture Health Group Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - NIL ) .

Venture Health Group Ltd (Registered number: 14519791)

Notes to the Financial Statements - continued
for the Year Ended 31 December 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£
COST
At 1 January 2024 957
Additions 963
At 31 December 2024 1,920
DEPRECIATION
At 1 January 2024 239
Charge for year 332
At 31 December 2024 571
NET BOOK VALUE
At 31 December 2024 1,349
At 31 December 2023 718

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£ £
Amounts owed by group undertakings 1,248 -
Other debtors 569,679 -
570,927 -

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£ £
Taxation and social security 220,457 110,869
Other creditors 437,261 3,161
657,718 114,030

7. ULTIMATE CONTROLLING PARTY

The issued share capital is held as follows:

25% - AHMSS Ltd, a company controlled by Dr S B Maddineni;
25% - Bstar Medical Limited, a company controlled by Dr J D Broome;
25% - Team Shax Limited, a company controlled by Dr D C Shackley;
25% - Tolofari Medical Limited, a company controlled by Dr S K Tolofari.